Last Updated on April 28, 2025 by The Health Master
USFDA approval
Mumbai-based JB Chemicals and Pharmaceuticals announced that it has received the United States Food and Drug Administration approval (USFDA approval) to market its generic version of Bisoprolol tablets.
This crucial USFDA approval of Bisoprolol tablets covers strengths of 5 milligrams (mg) and 10 mg, medications primarily used in the effective management of high blood pressure, also known as hypertension.
This development positions JB Chemicals to tap into the substantial US market for cardiovascular drugs.
A Cost-Effective Alternative to Zebeta
The USFDA approval of the drug that belongs to JB Chemicals is a generic equivalent of Teva Pharmaceutical Industries’ branded drug, Zebeta tablets.
The drug Zebeta is frequently prescribed by healthcare professionals in the United States for the management of hypertension.
The launching of a generic alternative like Bisoprolol from JB Chemicals is expected to increase competition in the market, giving the option for more affordable treatment options for patients.
Understanding Hypertension
Hypertension, or high blood pressure, is a health concern affecting millions worldwide.
If left unmanaged, it can lead to serious health issues such as heart disease, stroke, and kidney issues.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
USFDA approval granted for Rivaroxaban tablets
Tentative USFDA approval granted for Amifampridine Tablets
USFDA approval granted for Methenamine Hippurate Tablets: Zydus
USFDA approval granted for Ketoconazole Shampoo, 2%
Drug alert: 131 drug samples declared as NSQ in March 2025
Delhi appoints 17 new Drug Inspectors
Govt restricts Cold Medicine for Children Under Four
Huge stock of medicines seized in West Bengal
35 Unapproved Fixed Dose Combinations (FDCs) Under Scrutiny
Counterfeit Thrombophob ointment seized: Delhi
USFDA approval granted for Rivaroxaban tablets
FDA Maharashtra: Licenses of 89 Medical Stores cancelled
Drug recall: Glenmark, Sun Pharma, Zydus recall drugs
USFDA: No animal testing in drug development
USFDA inspection: At Aurobindo Pharma subsidiary with 11 observations
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
